Literature DB >> 11705909

Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections.

Y J Garin1, A Sulahian, F Pratlong, P Meneceur, J P Gangneux, E Prina, J P Dedet, F Derouin.   

Abstract

Human Leishmania infantum infection results in a spectrum of clinical expressions ranging from cutaneous to either asymptomatic or fatal visceral disease. In this context, characterization of parasite virulence appears to be relevant as a biological marker of intrinsic parasitic factors that can affect the pathology of leishmaniasis. Since parasite populations in naturally infected hosts are likely to be composed of multiclonal associations, we first explored the biodiversity of parasite virulence at the intrastrain level in vitro and in vivo by using 11 clones isolated from three strains previously known to express different virulence phenotypes in mice. Subsequently, we studied the course of infection in mice inoculated simultaneously or successively with strains or clones showing various virulence phenotypes. Analysis of in vitro growth characteristics showed no differences among clones from the different parental strains. By contrast, in vivo experiments evidenced a marked intrastrain heterogeneity of virulence to mice. One out of five clones obtained from a virulent strain showed a typical virulence phenotype, while the remaining four clones had low-virulence profiles, as did the six clones isolated from two low-virulence strains. In mixed multiclonal infections, the virulence phenotype was expressed as a dominant character over the associated low-virulence clones. After a challenge with either a homologous or a heterologous strain or clone, virulence phenotypes were conserved and expressed as in naive mice independently from the preexisting population. These results strongly suggest that parasite virulence in L. infantum visceral leishmaniasis is clonal and dominant in nature.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705909      PMCID: PMC98823          DOI: 10.1128/IAI.69.12.7365-7373.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Cutaneous leishmaniasis. The parasite.

Authors:  J P Dedet; F Pratlong; G Lanotte; C Ravel
Journal:  Clin Dermatol       Date:  1999 May-Jun       Impact factor: 3.541

2.  Leishmania infantum is clonal in AIDS patients too: epidemiological implications.

Authors:  M Jiménez; J Alvar; M Tibayrenc
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

3.  Sustained parasite burden in the spleen of Leishmania infantum-infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge.

Authors:  D Rousseau; S Demartino; F Anjuère; B Ferrua; K Fragaki; Y Le Fichoux; J Kubar
Journal:  Eur Cytokine Netw       Date:  2001 Apr-Jun       Impact factor: 2.737

4.  Evidence for determining parasitic factors in addition to host genetics and immune status in the outcome of murine Leishmania infantum visceral leishmaniasis.

Authors:  J P Gangneux; A Sulahian; S Honore; P Meneceur; F Derouin; Y J Garin
Journal:  Parasite Immunol       Date:  2000-10       Impact factor: 2.280

5.  Clonal variation within a mucosal isolate derived from a patient with Leishmania (Viannia) braziliensis infection.

Authors:  C A Cuba-Cuba; D Evans; A de C Rosa; P D Marsden
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 Sep-Oct       Impact factor: 1.846

6.  Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.

Authors:  E M Carvalho; O Bacellar; C Brownell; T Regis; R L Coffman; S G Reed
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

7.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

Authors:  H W Ghalib; M R Piuvezam; Y A Skeiky; M Siddig; F A Hashim; A M el-Hassan; D M Russo; S G Reed
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Leishmania infantum tropism: strain genotype or host immune status?

Authors:  L Gradoni; M Gramiccia
Journal:  Parasitol Today       Date:  1994-07

9.  Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts.

Authors:  J Kubar; P Marty; A Lelièvre; J F Quaranta; P Staccini; C Caroli-Bosc; Y Le Fichoux
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

10.  Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.

Authors:  D J Bradley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

View more
  12 in total

1.  Reduced antimony accumulation in ARM58-overexpressing Leishmania infantum.

Authors:  Carola Schäfer; Paloma Tejera Nevado; Dorothea Zander; Joachim Clos
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

2.  Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.

Authors:  Hector Nakayama; Philippe M Loiseau; Christian Bories; Susana Torres de Ortiz; Alicia Schinini; Elsa Serna; Antonieta Rojas de Arias; Mohamed A Fakhfakh; Xavier Franck; Bruno Figadère; Reynald Hocquemiller; Alain Fournet
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum.

Authors:  Paloma Tejera Nevado; Eugenia Bifeld; Katharina Höhn; Joachim Clos
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

4.  Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro.

Authors:  Linda Reiling; Mareike Chrobak; Christel Schmetz; Joachim Clos
Journal:  Mol Microbiol       Date:  2010-03-25       Impact factor: 3.501

5.  Antimony resistance in leishmania, focusing on experimental research.

Authors:  Fakhri Jeddi; Renaud Piarroux; Charles Mary
Journal:  J Trop Med       Date:  2011-11-17

6.  A2 gene of Old World cutaneous Leishmania is a single highly conserved functional gene.

Authors:  Yves J F Garin; Pascale Meneceur; Francine Pratlong; Jean-Pierre Dedet; Francis Derouin; Frédéric Lorenzo
Journal:  BMC Infect Dis       Date:  2005-03-28       Impact factor: 3.090

7.  In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.

Authors:  Jaume Carrió; Montserrat Portús
Journal:  BMC Pharmacol       Date:  2002-05-02

8.  New insights on taxonomy, phylogeny and population genetics of Leishmania (Viannia) parasites based on multilocus sequence analysis.

Authors:  Mariana C Boité; Isabel L Mauricio; Michael A Miles; Elisa Cupolillo
Journal:  PLoS Negl Trop Dis       Date:  2012-11-01

9.  A novel marker, ARM58, confers antimony resistance to Leishmania spp.

Authors:  Andrea Nühs; Carola Schäfer; Dorothea Zander; Leona Trübe; Paloma Tejera Nevado; Sonja Schmidt; Jorge Arevalo; Vanessa Adaui; Louis Maes; Jean-Claude Dujardin; Joachim Clos
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-12-06       Impact factor: 4.077

10.  Leishmania infantum Genetic Diversity and Lutzomyia longipalpis Mitochondrial Haplotypes in Brazil.

Authors:  Paulo Eduardo Martins Ribolla; Letícia Tsieme Gushi; Maria do Socorro Pires E Cruz; Carlos Henrique Nery Costa; Dorcas Lamounier Costa; Manoel Sebastião da Costa Lima Júnior; Maria Elizabeth Moraes Cavalheiros Dorval; Alessandra Gutierrez de Oliveira; Mirella Ferreira da Cunha Santos; Vera Lúcia Fonseca Camargo-Neves; Carlos Magno Castello Branco Fortaleza; Diego Peres Alonso
Journal:  Biomed Res Int       Date:  2016-03-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.